The Promising Horizon of Menstrual Blood Stem Cell Banking

Abstract

Menstrual Blood-Derived Stem Cells (MenSCs) have emerged as an innovative and promising source of mesenchymal stem cells (MSCs) with substantial potential in regenerative medicine. Their capacity to differentiate into a variety of cell types opens new therapeutic possibilities for previously untreatable conditions. MenSCs are distinct from traditional stem cell sources due to their non-invasive collection methods and recurring availability during menstrual cycles. This review highlights the therapeutic potential of MenSCs and discusses menstrual blood banking, which aligns with global trends and offers a sustainable, ethically sound source of biological material for advanced medical therapies. Clinical applications of MenSCs are actively being explored, demonstrating their versatility and therapeutic value. However, establishing MenSC banking involves several critical considerations, including standardizing collection and isolation procedures, ensuring donor safety, and maintaining stem cell quality. Ethical considerations, particularly within Islamic contexts, are also essential. Successful integration into clinical practice requires overcoming standardization challenges and addressing ethical considerations across diverse cultural contexts.